---
document_datetime: 2023-09-21 22:14:36
document_pages: 1
document_pathfilename: www.ema.europa.eu/en/documents/all-authorised-presentations/revestive-epar-all-authorised-presentations_en.pdf
document_name: revestive-epar-all-authorised-presentations_en.pdf
version: success
processing_time: 0.8541853
conversion_datetime: 2025-12-24 04:26:45.37596
docling_version:
  docling-serve: 1.9.0
  docling-jobkit: 1.8.0
  docling: 2.64.1
  docling-core: 2.55.0
  docling-ibm-models: 3.10.3
  docling-parse: 4.7.2
  python: cpython-313 (3.13.11)
  plaform: macOS-26.2-arm64-arm-64bit-Mach-O
---
| MA (EU) number   | (Invented) name   | Strength   | Pharmaceutical Form                           | Route of Administration   | Immediate Packaging                                       | Content (concentration)          | Pack size                         |
|------------------|-------------------|------------|-----------------------------------------------|---------------------------|-----------------------------------------------------------|----------------------------------|-----------------------------------|
| EU/1/12/787/001  | Revestive         | 5 mg       | Powder and solvent for solution for injection | Subcutaneous use          | powder: vial (glass); solvent: pre-filled syringe (glass) | Powder: 5 mg; Solvent: 0.5 ml    | 28 vials + 28 pre-filled syringes |
| EU/1/12/787/002  | Revestive         | 5 mg       | Powder and solvent for solution for injection | Subcutaneous use          | powder: vial (glass); solvent: pre-filled syringe (glass) | Powder: 5 mg; Solvent: 0.5 ml    | 1 vial + 1 pre-filled syringe     |
| EU/1/12/787/003  | Revestive         | 1.25 mg    | Powder and solvent for solution for injection | Subcutaneous use          | powder: vial (glass); solvent: pre-filled syringe (glass) | Powder: 1.25 mg; Solvent: 0.5 ml | 28 vials + 28 pre-filled syringes |